This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

ASCP Corner

Choice of Antipsychotic in HIV-Infected Patients

Dinesh Singh, MBChB, MMed (Psych), FCPsych, and Karl Goodkin, MD, PhD, FAPA

Published: March 15, 2007

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Human immunodeficiency virus (HIV) infection is associated with a wide range of mental illnesses.1-9 Some are due to HIV infection itself; others are higher in prevalence than among the general population due to a more frequent comorbidity associated with HIV risk factors. Psychosis is one that has been less frequently studied.’ ‹

Volume: 68

Quick Links: Psychiatry

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...